BMS’ Opdivo regimen shows promise in colorectal cancer clinical trials
BMS’ Opdivo plus Yervoy significantly improved progression-free survival in patients with MSI-H/dMMR metastatic colorectal cancer. Credit: Bristol-Myers Squibb Company. bristol myers squib (BMS) is a Phase III CheckMate-8HW clinical trial combining Opdivo (nivolumab) and Yervoy (ipilimumab) as a first-line treatment option for microsatellite-high instability (MSI-H) or mismatch repair deficiency (dMMR). reported promising data. Metastatic colorectal […]
The man thought the pain was caused by a new exercise regimen. he had cancer.
When JJ Singleton noticed a throbbing pain in her abdomen in May 2015, she chalked it up to a torn muscle. After all, the 27-year-old’s goals for this year are: “Let’s get our lives together,” that’s how he started 2015. crossfit Train with your old soccer coach. singleton, Now 36, he told Business Insider that […]